George Syrmalis
Executive Chair, Chief Executive / IQ3CORP
Dr George Syrmalis is the executive chair and chief executive of The iQ Group Global. He founded the company in 2010 to converge investment banking, scientific discovery, corporate advisory and commercialisation, and to bring medical innovations to the world.
Between 1995 and 2005, he founded and led The Bionuclear Group SA as chief executive and chair, incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA and Vitalcheck SA.
Dr Syrmalis is a fellow of the American Academy of Pharmaceutical Physicians, the American College of Nuclear Physicians, the American College of Nuclear Medicine, and the New York Academy of Sciences.
